Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: procedure (650), etiquette (1), practice (609)

REPOCH (dose adjusted)-Cyclophosphamide-Doxorubicin-Etoposide-Prednisolone-Rituximab-Vincristine

Description: Chemotherapy Protocol LYMPHOMA REPOCH - CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE-PREDNISOLONERITUXIMAB-VINCRISTINE (Dose adjusted regimen) There are multiple versions of this protocol in use
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/REPOCH-dose-adjusted-Cyclophosphamide-Doxorubicin-Etoposide-Prednisolone-Rituximab-Vincristine.pdf

InP-REPOCH-Cyclophosphamide-Doxorubicin-Etoposide-Prednisolone-Rituximab-Vincristine

Description: Chemotherapy Protocol LYMPHOMA REPOCH - CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE-PREDNISOLONERITUXIMAB-VINCRISTINE (In-Patient Dose adjusted regimen) There are multiple versions of thi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-REPOCH.pdf

InP-PAM-(cycles 5-6) v1

Description: Chemotherapy Protocol Sarcoma DOXORUBICIN-METHOTREXATE (cycles 5-6) Inpatient Regimen There are multiple versions of this protocol in use. Please ensure
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-PAM-cycles-5-6-v1.pdf

Ruxolitinib

Description: Chemotherapy Protocol Myelofibrosis Ruxolitinib Regimen • Myelofibrosis – Ruxolitinib Indication • Ruxolitinib is recommended as an option for treating disease-related splenomegaly or symptoms
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myelofibrosis/Ruxolitinib.pdf

HSCTMelphalan-Bortezomib IV

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT InP - MELPHALAN and BORTEZOMIB (IV) Please confirm correct protocol with transplant schedule Regimen • HSCT – InP - Melphalan
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTMelphalan-Bortezomib-IV.pdf

Carboplatin(AUC2)-Paclitaxel RT

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CARBOPLATIN (AUC2)-PACLITAXEL-RADIOTHERAPY Regimen • Gastrointestinal (Upper) Cancer – Carboplatin(AUC2)-Paclitaxel-Radiotherapy Indication • Neoadjuvant treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/CarboplatinAUC2-Paclitaxel-RT.pdf

Capecitabine-Cetuximab-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-CETUXIMAB-OXALIPLATIN (21 day) This regimen may require funding Regimen • Colorectal Cancer – Capecitabine-Cetuximab-Oxaliplatin (21
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Cetuximab-Oxaliplatin.pdf

DOC CRF User Guidelines

Description: SCBR University Hospital Southampton NHS Foundation Trust GUIDELINES FOR USERS OF THE SOUTHAMPTON NIHR CLINICAL RESEARCH FACILITY (CRF) Welc
Url: /Media/Southampton-Clinical-Research/BRC-CRF-templates/DOC-CRF-User-Guidelines.pdf

Gefitinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEFITINIB Regimen NSCLC - Gefitinib Indication Gefitinib is recommended as an option for the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gefitinibver13.pdf

GvHDProphylaxisMethotrexateTReplete

Description: Chemotherapy Protocol SUPPORT REGIMEN–GvHD PROPHYLAXIS METHOREXATE – T Replete Allograft Graft versus Host Disease (GvHD) Prophylaxis This regimen will only be
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/GvHDProphylaxisMethotrexateTReplete.pdf

81 to 90 of 698

Previous … 7 8 9 10 11 … Next